NewsRx

Search our medical news database

Orthopedic Pain Disorders

Clinical Trials Advanced for Orthopedic Shock Wave Therapy

Published in Medical Letter on the CDC and FDA, May 16th, 2000

Siemens Medical Systems, Inc., Iselin, New Jersey, received conditional approval from the U.S. Food and Drug Administration to continue clinical testing of the Siemens Sonocur, a sound wave therapy device that is currently marketed in Europe and Canada for the treatment of chronic orthopedic pain disorders.

In the United States, clinical evaluation of the Sonocur as a pain therapy system has been underway since 1999 and has focused on the treatment of patients with lateral epicondylitis, a disease commonly known as chronic tennis elbow. Tennis elbow is a common tendon irritation, which is often caused by repetitive motion of the hand and forearm.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook